BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

RECURSION — Lobbying — Receipts Report

LD-2 disclosure · 1st Quarter - Report

RECURSION

via ATLAS CROSSING LLC

1st Quarter (Jan 1 - Mar 31) · 2024Posted Apr 22, 2024Filing document ↗LDA record ↗

Income$50Kfee reported

Client

Name: RECURSION
Description: Clinical-Stage TechBio Company.
Location: Utah · United States of America

Registrant

Firm: ATLAS CROSSING LLC
Description: Consulting firm.
Location: Washington, District of Columbia, United States of America

Lobbying activities

1 issue

Science/Technology
Issues related to artificial intelligence and machine learning. Issues related to infectious diseases. Issues related to drug discovery.
LobbyistsSEAN JOYCE · ALEXIS OBERG · CHRISTOPHER W EDDOWES · mr CHRISTOPHER SWEET · CHRISTOPHER KIM · TIMOTHY MONAHAN
Covered position (CHRISTOPHER KIM): Intern, U.S. Rep. Bill Huizenga
Covered position (TIMOTHY MONAHAN): Sr. Advisor, Rep. Mike Johnson; Dir. House Operations, Rep. Kevin McCarthy; Staff/Deputy Staff Dir., Comm. on House Admin; Prof Staff, House Approps Comm.; Asst Chief Logistics Officer/Special Asst/Project Mgr House CAO; Dir., CAO IO Operations
TargetedSENATE · HOUSE OF REPRESENTATIVES · Food & Drug Administration (FDA) · Natl Institutes of Health (NIH)

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.